"This signifies an exciting opportunity for ValiRx to further expand its portfolio of innovative cancer therapeutics", all of which to date appear unloved, stagnant and a financial desert. This latest rns means that however interesting, time will be spent paying people not to generate revenue over a minimum of 12 months - and do they mean Val months or earth months. Because 12 Val months seem to equate to about 36 earth months or more.
Still not an incentive to buy shares here. The crew are now engaged in rearranging the deck chairs on the Titanic while they discuss who they want to be Captain, assuming they can find a volunteer on what will have to be a pretty low salary. I'll guess some fanfare appointment in a couple of months to support a(nother) raise.
The resurrected post to which PM objects is only a couple of weeks older than the 2nd November 2021 RNS which said of the 'deal' with Theoremrx 'The first payments are expected by the end of 2021.'
So the LOI and TheoremRx dealings are by your definition irrelevant. I have to agree with you on that basis.
Now he's assuming other people's gender. (Presuming he's also actually a he and not an amoeboid zingatularian or something)
That's like saying 'her twitter account has gone and rumour is she'll be resigning quite soon.'
SD's Twitter/X account seems to have disappeared. Is this significant? It leaves me somewhat devoid of confidence and concerned.
If they work it hard it could get the bid to just around 33 percent below the last raise price. Would that be a cause for rejoicing...?
Apologies, remember it now. It's an age thing probably.
When was it £1.40?
Just 88 percent down. Better than anyone who was here before even the latest consolidation, and that explains why Suzy hasn't put any real money in here - she's probably a lot more switched on that she appears to some.
PM - 'Adam was saying 10/20 million upfront for that alone and he would know more than any of us.'
He also owns about 7 percent of the company, so is he really being objective, or just trying desperately to stop his outlay from going down the pan any further?
I presume you're talking 20p for the company rather than per share?
Or the alternative Dracula 'I'm not pessimistic but' line - "All these conferences going on and they aren't presenting. What's wrong with the science?"
To be fair it's had considerable trader interest over the years, often quite intrusively, and as far as 'unloved' goes, Vulpes and Redmile seemed affectionate enough to stick many tens of millions into it after very considerable due diligence. Patience is a virtue.
'Everybody happy with a £1?' - very reminiscent of the old guard who would propose something, talk about it for a bit, then say 'We are all agreed....'
Any 'final' price relies on the assumption there will be a buyout, so a big string of 'ifs.' Very tiresome.
It's probably worth clarifying a couple of things which keep cropping up and tend to get a little distorted at times - one is that Redmile (and Vulpes and Calculus) are not quick buck fly-by-night setups. If they consider today's share price 'derisory' then imo they are not likely to grab the first low ball offer that pops up, especially given the recent progress and quality of the current trials. The data is very good, and expected to increase in quality and volume. Not the point to bale out I would say.
Second point where the basic facts seem to get ignored - if Redmile's holding does go over 30 percent, yes they are required to make an offer for the whole company. However, the board and shareholders are not obliged to accept it, in which case Redmile simply carry on with an increased shareholding. There seems to be a mentality that promotes the idea that crossing the 30 percent holding means an immediate buyout at a low price. Wrong.
Sit back, relax, enjoy the ride folks.
I bet they don't manage to string out calling an EGM for two and a half years like they have with the TheoremRx farce. So at least that will be proof they can meet a deadline when under pressure.
If ever an RNS was announced through gritted teeth, this is it.
Presumably the Little Soap Company does beauty products for some of those elderly mice.
C11 - probably as he finds it hard to be objective with all those splinters in his posterior from sitting on the fence and gyrating every which way.